Arrowstreet Capital, Limited Partnership Veracyte, Inc. Transaction History
Arrowstreet Capital, Limited Partnership
- $122 Billion
- Q4 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Veracyte, Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 635,110 shares of VCYT stock, worth $24.9 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
635,110
Previous 271,248
134.14%
Holding current value
$24.9 Million
Previous $9.23 Million
172.48%
% of portfolio
0.02%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding VCYT
# of Institutions
337Shares Held
80.2MCall Options Held
212KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA8.21MShares$322 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$305 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$259 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$165 Million1.46% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$160 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.8B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...